More News

20 Apr 2007 Access Pharmaceuticals Signs Definitive Merger Agreement With Somanta Pharmaceuticals
20 Apr 2007 Access Pharmaceuticals Signs Definitive Merger Agreement With Somanta Pharmaceuticals
19 Apr 2007 Completion of Phase I Trial on the Anti-influenza Drug CS-8958
19 Apr 2007 Vasogen and Grupo Ferrer Form Collaboration to Commercialize Celacade(TM) in the European Union
19 Apr 2007 Vasogen and Grupo Ferrer Form Collaboration to Commercialize Celacade(TM) in the European Union
19 Apr 2007 Viragen Announces European Multiferon(R) Licensing Agreement
18 Apr 2007 DeveloGen and Andromeda, a newly formed wholly-owned subsidiary of Clal Biotechnology Industries, Sign Term Sheet for Asset Purchase Agreement for the DiaPep277(R) Program
18 Apr 2007 Wockhardt to soon introduce Kelocote to treat scars
18 Apr 2007 Wockhardt to soon introduce Kelocote to treat scars
18 Apr 2007 Prevascar Phase II Results
18 Apr 2007 Salix Pharmaceuticals Licenses DIACOL(TM) To Dr. Falk Pharma in Europe
17 Apr 2007 Cambridge Antibody Technology and Philochem Announce Technology Evaluation Agreement
17 Apr 2007 Arrowhead Subsidiaries Insert & Calando Present Data on Cyclosert Drug Delivery System at AACR Meeting
17 Apr 2007 Regulatory Review Allows LCT Diabetes Clinical Program to Proceed
17 Apr 2007 Metabasis Therapeutics Presents Results of a Clinical Study for Its Novel Liver-Targeted Product Candidate for the Treatment of HCC at American Association for Cancer Research
14 Apr 2007 Syndax Pharmaceuticals, Inc. Licenses Selective Histone Deacetylase Inhibitor MS-275
14 Apr 2007 Mylan Announces Final FDA Approval for Glipizide and Metformin Hydrochloride Tablets
13 Apr 2007 MedImmune Explores Strategic Alternatives
13 Apr 2007 Intarcia Therapeutics Announces Final Results From A Phase 2 Study Of Injectable Omega Interferon plus Ribavirin for the Treatment of Hepatitis C Genotype-1
13 Apr 2007 Coley Pharmaceutical Group Licenses VaxImmune(TM) to Merck for Use in Vaccine Programs
13 Apr 2007 Ranbaxy Receives FDA Approval To Market Loratadine Antihistamine Tablets
13 Apr 2007 Anika Therapeutics Receives CE Mark Approval for its Cosmetic Tissue Augmentation Product ELEVESS(TM) to be Marketed by Galderma
12 Apr 2007 Roche and Transgene enter partnership on therapeutic vaccines against HPV-mediated diseases
12 Apr 2007 Novosom AG Acquires Exclusive Option for CD40-Targeted Antisense Inhibitors From Isis Pharmaceuticals
12 Apr 2007 Xanthus Acquires from Johns Hopkins University Exclusive License to Patent Estate Covering FLT3 Pathway as a Target for Treating Autoimmune Diseases

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top